Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label at the bottom changes from v3.5.2 to v3.5.3, indicating a minor site release update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.2 and remove v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:38:20.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updated the page’s revision tag from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:48:46.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T20:39:33.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No user-facing content or study information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:17:59.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; no substantive study details, outcomes, or eligibility information appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T17:24:00.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.